Animal Models of Human PathologyView this Special Issue
Research Article | Open Access
Ling-Hua Tang, Zhong-Yuan Xia, Bo Zhao, Xiao-Dong Wei, Tao Luo, Qing-Tao Meng, "Phosphocreatine Preconditioning Attenuates Apoptosis in Ischemia-Reperfusion Injury of Rat Brain", BioMed Research International, vol. 2011, Article ID 107091, 4 pages, 2011. https://doi.org/10.1155/2011/107091
Phosphocreatine Preconditioning Attenuates Apoptosis in Ischemia-Reperfusion Injury of Rat Brain
Phosphocreatine (PCr) is an endogenous compound containing high-energy phosphate bonds. It has been confirmed that PCr is effective in preventing and treating cardiac and renal ischemia-reperfusion injury. In this study, rat cerebral ischemia-reperfusion injury models were constructed. Apoptotic cells in the cortex region were measured by TUNEL method. Malondialdehyde (MDA) content was detected by chromatometry, and calmodulin (CaM) activity was detected by ELISA. Compared with sham-operated group (sham group), TUNEL-positive cells, MDA, and level of CaM activity increased in ischemia-reperfusion group (I/R group) and PCr preconditioning group (PCr group); compared with I/R group, TUNEL-positive cells, MDA content, and level of CaM activity decreased in PCr group. This study indicated that PCr can decrease the morphological damage and the neuron apoptosis of the ischemia-reperfusion injury brain through attenuating abnormalities of calcium balance and production of oxygen free radicals.
Acute cerebral ischemic reperfusion injury (CIRI), a hotspot for clinical research, is a pathophysiologic phenomenon commonly encountered in the field of emergency medicine, especially during the perioperative periods. The brain can store so little energy reserves that it is highly sensitive to ischemia and hypoxia. Studies have shown that interrupting the cerebral blood flow for 10 s can lead to loss of consciousness. If cerebral blood flow is blocked for more than 5 min, permanent brain damage is inevitable . Phosphocreatine (PCr) has been used as cardioplegic and cardioprotective agents during cardiopulmonary bypass and also ischemic events . In recent years, some reports showed that PCr improved the outcome after stroke and neonatal hypoxic ischemic encephalopathy . There have been no studies done to investigate the effect of PCr during acute CIRI. So we designed this research using acute rat CIRI model to observe the effect of PCr and investigate its possible mechanism.
2. Materials and Methods
All experimental procedures were done in accordance with the guide for the care and use of laboratory animals. All surgical procedures have been approved by the committee for experimental animals of Centre for Disease Control and Prevention of Hubei Province. 36 male Wistar rats weighing 200~220 g were acquired from the Experimental Animal Center of Hubei Province, Wuhan, China. Sodium creatine phosphate injection was purchased from Haikou Kellett Pharmaceutical Co., China.
2.2. Animal Model and Grouping
36 Wistar rats were randomly divided into 3 groups: sham-operated group (sham group, ), ischemia-reperfusion group (I/R group, ), PCr preconditioning group (PCr group, ). The rats were anesthetized by 10% chloral hydrate. CIRI rat models were produced by electrocauterizing bilateral vertebral arteries and occlusion of bilateral common carotid arteries using atraumatic clasps . It was considered a success as the eyeballs turn white and pupils were dilated. The clasps were released 10min later and followed by a 48-hour reperfusion. In sham group, bilateral common carotid arteries were exposed but not clamped. In PCr group, PCr 150 mg·kg−1 was administered intravenously 60 min before the bilateral common carotid arteries were occluded; normal saline was administered intravenously in I/R group simultaneously. Core body temperatures were monitored with a rectal probe and maintained between 36.5°C~37.5°C during the whole procedure. 3 rats from I/R group and 1 from PCr group were excluded within 24 h while the remaining ones were regarded as successful models.
2.3. HE Staining, Light Microscopy
After routine HE staining, pathological changes of the brain tissue were observed under a light microscopy (×400).
2.4. TUNEL Staining
The level of cell apoptosis was determined with a Roche in situ cell-apoptosis-assay kit with nuclei stained in brown particles (Shanghai Runwell Technology Co., China). 10 high-power fields (×400) were randomly selected, and the number of apoptotic cells was counted for each field.
2.5. Assay of CaM Activity and MDA Content
CaM activity (mmol·L−1) was measured using rat CaM ELISA kit (R & D Company, US); MDA content (nmol·L−1) was detected with MDA kit; protein content (mg·L−1) in corresponding tissue was detected with Coomassie brilliant blue protein assay kit (both from Nanjing Jiancheng Bio Co., China). MDA content in the tissue was calculated using the following formula:
2.6. Statistical Analysis
Results were expressed as mean ± SD. Data were statistically evaluated by one-way ANOVA (SNK) tests and Dunnett’s tests, with the level of significance chosen as .
3.1. Brain Pathologic Changes
In sham group, the cortical neurons are arranged in neat rows with abundant cytoplasm, and the nuclei are round and basophilic. In I/R group, the structures of the cortical neurons are damaged. The cytoplasm is light red with uneven distribution and vacuoles, nuclei are condensed. In PCr group, however, the cell structure is normal. Most of the neurons have complete membrane integrity and the nuclei are clear (Figure 1).
3.2. PCr Preconditioning Reduced Cell Apoptosis
A few TUNEL-positive cells were observed in the cortex of rats in sham group whereas a large number of TUNEL-positive cells was observed in the cortex of rats subject to I/R injury; compared with I/R group, the number of TUNEL positive cells was significantly reduced in the cortex of PCr group (Figures 2 and 3).
3.3. CaM Activity
CaM activity was 4.328 ± 0.422 mmol/L in sham group. The CaM activity of I/R group and PCr group was significantly increased at 48 hours after reperfusion compared with sham group whereas CaM activity was significantly decreased in the cortex of PCr group compared with I/R group (Figure 4).
3.4. MDA Content
MDA content was 4.792 ± 0.451 nmol/mgprot in sham group. MDA in I/R group and PCr group was significantly increased at 48 hours after reperfusion compared with sham group, but compared with I/R group, MDA content was significantly decreased in the cortex of PCr group (Figure 5).
Rapid exhaustion of energy is one of the important etiological factors of ischemia-reperfusion injury [5, 6]. We hypothesized that supplication of an exogenous energy substrate before ischemic reperfusion might be an important logical therapeutic step. PCr is a very important energy substrate , it can go through the blood-brain barrier, even through the cell membrane, to supply energy to cells directly. It possesses 3-times FDP and 1.5-fold of ATP energy level. In this study, we have demonstrated that PCr preconditioning attenuated cell apoptosis and the morphological damage during cerebral ischemia-reperfusion in rats. In ischemia-reperfusion injury brain, the apoptotic neurons extensively exist. The cytoplasm is light red with uneven distribution and vacuoles, and nuclei are condensed under light microscopy after reperfusion for 48 h. Compared with I/R group, the number of apoptotic cells was significantly decreased and cerebral ischemia-reperfusion injury was alleviated in PCr group.
Imbalance of neuronal calcium homeostasis and increase in oxygen free radical are important aggravating factors of cerebral ischemic reperfusion injury . Energy deficiency causes intracellular calcium overload and an increase in oxygen free radical. To assess the intracellular Ca2+ overload and oxygen free radical level, CaM activity and cerebral MDA content were determined. CaM is a calcium-binding protein. It combines with Ca2+ reversibly, and regulates transmembrane calcium transportation, absorption, and secretion. An increase in activity of CaM means an elevation of intracellular ionized Ca2+ concentration, hence causing calcium imbalance in the cells . MDA is a stable lipid peroxide end product produced during the oxidation of membrane lipid unsaturated fatty acid by oxygen free radical. The central nervous system is rich in unsaturated fatty acids that interact with oxygen free radical during reperfusion after an ischemic event, which generates a large amount of MDA. Therefore, MDA level indirectly reflects the level of oxygen free radical and the degree of lipid peroxidation in the brain tissue.
We found that the CaM activity was elevated in I/R group compared with sham group, indicating the increase of Ca2+ influx, Ca2+ overload, and Ca2+ balance disturbance. The high MDA content in I/R group suggested that oxidative stress occurred and a large amount of lipid peroxide was produced. PCr group demonstrated a significantly lower CaM activity. Thus, there were lower incidences of Ca2+ reflux, Ca2+ overload, and complex pathological changes induced by Ca2+ overload. PCr group also had lower MDA level, indicating that PCr induced a significant suppression in the generation of free radical and provided an antioxidative protection to the cell and organelle membranes, hence attenuating cellular necrosis and apoptosis.
During ischemia-reperfusion, Ca2+ overload leads to mitochondrial dysfunction, and oxygen free radical increases . We have found that PCr preconditioning decreases CaM activity, thus preventing calcium overload, reducing the production of oxygen free radical indirectly. As an ATP precursor, PCr releases high-energy phosphate bond to synthesize ATP, supplying neurons with energy, reducing the production of lactic acid, and maintaining the function of Na+-Ca2+ exchange . It is suggested that PCr preconditioning ensures sufficient ATP supply, keeps Ca2+ pump working, and sustains Ca2+ balance . It can also inhibit the formation of Hypoxanthine, thereby reducing the production of oxygen free radicals .
Currently, the methods of preconditioning include mechanical preconditioning and pharmacologic preconditioning. The drawback of clinical application of mechanical preconditioning is the difficulty in predicting the onset of any ischemic event. Even if it’s predictable, the application of a transient mechanical preconditioning is impractical before cerebral ischemia. Therefore, the clinical application of mechanical preconditioning was limited.
One of the important etiological factors of ischemia-reperfusion injury is due to the rapid exhaustion of energy [5, 6]. Therefore, a supply of an exogenous energy substance during ischemic reperfusion may be an important logical therapeutic step. Phosphocreatine (PCr) is an endogenous compound containing high-energy phosphate bonds. It acts as an energy reserve, and it is mainly synthesized by the kidneys. The finding of the current study provides a promising method for the treatment of cerebral ischemia-reperfusion injury. However, only brain pathological and apoptotic changes were investigated in the current study. Future study will be needed to further evaluate the effect of PCr on brain infarct size, neurological score and so forth. The assessment of functional and histological endpoints as well as multiple neurological outcomes will allow better understanding of the PCr’s role in brain ischemia.
In summary, we demonstrated the protective effect of PCr during cerebral ischemic reperfusion injury. Based on the pharmacokinetic characteristics of PCr, we speculate that PCr should be administered preoperatively to hemodynamic unstable patients, such as aortic aneurysm surgical patients, who may develop cerebral ischemia during surgery when the major arteries are clamped. Other patients with severe head injury, hemorrhagic shock, cerebral vasospasm, and respiratory and cardiac arrest may also benefit from the protection against cerebral ischemic reperfusion injury.
This work was sponsored by the National Nature Science Foundation of China (Grant no. 30672033).
- T. Yao and Z. Q. Ruo, Physiology , vol. 177, People’s Health Press, 1st edition, 2005.
- D. J. Chambers, K. Haire, N. Morley et al., “St. Thomas' hospital cardioplegia: enhanced protection with exogenous creatine phosphate,” Annals of Thoracic Surgery, vol. 61, no. 1, pp. 67–75, 1996.
- M. Balestrino, M. Lensman, M. Parodi et al., “Role of creatine and phosphocreatine in neuronal protection from anoxic and ischemic damage,” Amino Acids, vol. 23, no. 1–3, pp. 221–229, 2002.
- W. A. Pulsinelli and J. B. Brierley, “A new model of bilateral hemispheric ischemia in the unanesthetized rat,” Stroke, vol. 10, no. 3, pp. 267–272, 1979.
- M. Parodi, R. Rebaudo, L. Perasso, C. Gandolfo, A. Cupello, and M. Balestrino, “Effects of exogenous creatine on population spike amplitude and on postanoxic hyperexcitability in brain slices,” Brain Research, vol. 963, no. 1-2, pp. 197–202, 2003.
- A. Ames III, “CNS energy metabolism as related to function,” Brain Research Reviews, vol. 34, no. 1-2, pp. 42–68, 2000.
- G. Prabhakar, L. Vona-Davis, D. Murray, P. Lakhani, and G. Murray, “Phosphocreatine restores high-energy phosphates in ischemic myocardium: implication for off-pump cardiac revascularization,” Journal of the American College of Surgeons, vol. 197, no. 5, pp. 786–791, 2003.
- Y. Shirasaki, Y. Kanazawa, Y. Morishima et al., “Involvement o f calmodulin in neuronal cell death,” Brain Research, vol. 1083, no. 1, article 189, 2006.
- T. Sato, H. Takamori, and Y. Shirasaki, “DY-9760e, a novel calmodulin antagonist, reduces infarction after permanent focal cerebral ischemia in rats,” Pharmacology, vol. 71, no. 1, pp. 38–45, 2004.
- S. Yano, M. Morioka, J.-I. Kuratsu, and K. Fukunaga, “Functional proteins involved in regulation of intracellular Ca2+ for drug development: role of calcium/calmodulin-dependent protein kinases in ischemic neuronal death,” Journal of Pharmacological Sciences, vol. 97, no. 3, pp. 351–354, 2005.
- Z.-C. Feng, T. J. Sick, and M. Rosenthal, “Oxygen sensitivity of mitochondrial redox status and evoked potential recovery early during reperfusion in post-ischemic rat brain,” Resuscitation, vol. 37, no. 1, pp. 33–41, 1998.
- F. Zhang, Z. Xu, J. Gao, B. Xu, and Y. Deng, “In vitro effect of manganese chloride exposure on energy metabolism and oxidative damage of mitochondria isolated from rat brain,” Environmental Toxicology and Pharmacology, vol. 26, no. 2, pp. 232–236, 2008.
Copyright © 2011 Ling-Hua Tang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.